Turing Pharmaceuticals was warned by New Yorks attorney general that the distribution network for a rarely used cancer drug may violate antitrust laws.

Pharmaceutical companies are pouring millions of dollars into an effort to head off a state ballot initiative that would rein in spending on medicine.

To improve its image as a wellness company, Target will offer Fitbits to employees and promote more healthy foods.

Pharmaceutical makers are fitting drug trial participants with fitness trackers in hopes of streamlining trials. Someday, these wearables also could help prove to insurance companies that treatments are working.

Sprouts controversial "female Viagra" pill received approval on Tuesday from the FDA--now Valeant is buying Sprout.

Google's biotech firm Calico partners with Ancestry.com to get access to DNA information and public family trees created by consumers.

Novartis plans to offer an outcomes-based plan for its newly approved drug Entresto, but it's unclear how tracking of patients would occur.

The FDA hopes to learn more about drug side effects from data on a patient network called PatientsLikeMe.